PT  - JOURNAL ARTICLE
AU  - Jain, Rohit
AU  - Yang, Yuanquan
AU  - Chadha, Juskaran
AU  - Chatwal, Monica
AU  - Raymond, Sarah
AU  - Saunders, Erika
AU  - Poehlman, Trey
AU  - Fan, Wenyi
AU  - Kim, Youngchul
AU  - Dhillon, Jasreman
AU  - Mortazavi, Amir
AU  - Zhang, Jingsong
AU  - Sonpavde, Guru P
TI  - 662 Phase I/II study of ipilimumab plus nivolumab combined with sacituzumab govitecan in patients with metastatic cisplatin-ineligible urothelial carcinoma
AID  - 10.1136/jitc-2023-SITC2023.0662
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A754--A754
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A754.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A754.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.